obesity drug news today glp-1 october 23 2025 Outlook for in 2025: more than a transition year GLP-1 Overdoses Are Rising as

For example, if you are taking blood pressure or cholesterol-lowering medication, the same dose may become too strong after substantial weight loss

The pharmaceutical company highlights that both primary endpoints were to demonstrate that oral Foundayo or Zepbound continuation at either the reduced dose or MTD was superior to placebo in maintaining body weight reduction

doi: 10.1152/ajpendo.00347.2016

Heart rate increases were not associated with adverse cardiac events in the trials, but it is something researchers monitor closely

While we still need more data, I think GLP-1s deserve a place in the conversation for patients with PCOS, insulin resistance, or obesity who are struggling to conceive.

He personally performs every treatment never delegating injections or procedures to assistants or PAs